The FDA Issues Warning Letters

The FDA sent 15 companies warring letters this week, regarding allegedly selling products that contain cannabidiol in way that ..nolate the Federal Food Drug and Cosmetic ACT. The FDA stated that based on the lack of scientific information supporting the safety of CBD in food it cannot conclude that CBD is generally recognized as safe (GRAS). The FDA had primarily maintained CBD prohibited in comentional food products because substantial clinical investigations were initiated and made public on a drug containing CBD. FDA continues to explore potential pathways for various types of CBD products to be lawfully marketed and plans to provide an update on its progress in the coming weeks.

A New public guidance for CBD consumers was also issued by the FDA, it highlights the concerns about possible health risk and stresses that it has “seen only on limited data about CBD safety”.

SENPA will continue to monitor any progress concerning this matter.